Sort By

Hyperlipidemia Type 3 Approved Drugs

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hyperlipidemia Type 3.

Found 3 Approved Drugs for Hyperlipidemia Type 3

Rosuvastatin

Brand Names
Roszet, Crestor, Ezallor
Form: Tablet, Capsule
Method of administration: Oral
FDA approval date: August 18, 2003
Classification: HMG-CoA Reductase Inhibitor
Pediatric use information for patients 7 to 17 years of age is approved for AstraZeneca’s CRESTOR (rosuvastatin calcium)tablets. However, due to AstraZeneca’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. Rosuvastatin is an HMG Co-A reductase inhibitor indicated for: adult patients with hypertriglyceridemia as an adjunct to diet.

Atorvastatin

Brand Names
Prestalia, Lotrel, Lipitor, Katerzia, Amlodipine, Benazepril, Amlodipine Besylate, Azor, Caduet, Norliqva, Lotensin, Olmesartan Medoxomil, AMOLDIPINE Benazepril, Tribenzor, Norvasc
Form: Tablet, Suspension, Capsule, Solution
Method of administration: Oral
FDA approval date: June 21, 1991
Classification: HMG-CoA Reductase Inhibitor
Amlodipine besylate tablet, USP is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension.

Pravastatin

Generic Name
Pravastatin
Form: Tablet
Method of administration: Oral
FDA approval date: April 25, 2006
Classification: HMG-CoA Reductase Inhibitor
Pravastatin sodium tablet, USP is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: Reduce the risk of MI, revascularization, and cardiovascular mortality in hypercholesterolemic patients without clinically evident CHD.
Showing 1-3 of 3
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances